Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
dupilumab
Biotech
Pfizer beats blockbuster Dupixent in phase 3 eczema trial
Pfizer chalked up an efficacy win over the blockbuster incumbent without sharing key details of safety data that could shape the category.
Nick Paul Taylor
Aug 30, 2021 8:55am
AstraZeneca drops tezepelumab from atopic dermatitis pipeline
Jul 29, 2021 6:19am
Pfizer's abrocitinib aces 5th phase 3 on route to FDA decision
Nov 11, 2020 8:05am
Aslan hopes to roar again as Dupixent rival test resumes
Aug 24, 2020 7:10am
Safety issues for Pfizer's Dupixent rival may hamper uptake
Jun 4, 2020 11:10am
Could Dupixent also treat age-related macular degeneration?
May 7, 2020 8:15am
